Vivek Ramaswamy’s Roivant group has forged its biggest and most wide-ranging alliance to date, licensing dozens of drugs to Japan’s Sumitomo Dainippon Pharma in deal that includes a massive $3 ...

A new international biotech – Sumitovant Biopharma – has been created after Sumitomo Dainippon’s strategic alliance with Roivant Sciences came to fruition as 2019 drew to a close.

Meanwhile, Concordia Financial Group Ltd (TYO:7186) added 4.82% or 37.20 points to end at 808.80 and Sumitomo Dainippon Pharma Co Ltd (TYO:4506) was up 3.68% or 14.00 points to 393.00 in late trade.

Investing.com – Japan stocks were higher after the close on Monday, as gains in the Mining, Chemical, Petroleum&Plastic and Warehousing sectors led shares higher. At the close in Tokyo, the ...